BiVACOR(R) Total Artificial Heart Early Feasibility Study.

The article discusses a clinical trial, NCT06174103, that is currently recruiting participants to assess the feasibility of using the BiVACOR Total Artificial Heart (TAH) System for adult patients with severe biventricular or univentricular heart failure. The trial aims to evaluate the safety and performance of the BiVACOR TAH System as a bridge to transplant for patients who require mechanical circulatory support. The document also provides guidelines for biventricular support, outlining eligibility criteria and exclusion criteria. The study is being conducted by BiVACOR Inc., and contact information for the primary contact is provided. The document does not mention the location countries or data sharing plans. [Extracted from the article]